Logo image of DCTH

DELCATH SYSTEMS INC (DCTH) Stock Fundamental Analysis

NASDAQ:DCTH - Nasdaq - US24661P8077 - Common Stock - Currency: USD

14.88  -0.66 (-4.25%)

After market: 15.5 +0.62 (+4.17%)

Fundamental Rating

3

DCTH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. While DCTH seems to be doing ok healthwise, there are quite some concerns on its profitability. DCTH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DCTH has reported negative net income.
DCTH had a negative operating cash flow in the past year.
DCTH had negative earnings in each of the past 5 years.
DCTH had a negative operating cash flow in each of the past 5 years.
DCTH Yearly Net Income VS EBIT VS OCF VS FCFDCTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M

1.2 Ratios

DCTH has a worse Return On Assets (-107.71%) than 86.17% of its industry peers.
The Return On Equity of DCTH (-398.13%) is worse than 85.64% of its industry peers.
Industry RankSector Rank
ROA -107.71%
ROE -398.13%
ROIC N/A
ROA(3y)-135.11%
ROA(5y)-107.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DCTH Yearly ROA, ROE, ROICDCTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

1.3 Margins

Looking at the Gross Margin, with a value of 81.31%, DCTH belongs to the top of the industry, outperforming 94.15% of the companies in the same industry.
DCTH's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for DCTH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.2%
GM growth 5Y-0.32%
DCTH Yearly Profit, Operating, Gross MarginsDCTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

More info and screens

5

2. Health

2.1 Basic Checks

DCTH does not have a ROIC to compare to the WACC, probably because it is not profitable.
DCTH has more shares outstanding than it did 1 year ago.
DCTH has more shares outstanding than it did 5 years ago.
DCTH has a better debt/assets ratio than last year.
DCTH Yearly Shares OutstandingDCTH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
DCTH Yearly Total Debt VS Total AssetsDCTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

DCTH has an Altman-Z score of -12.24. This is a bad value and indicates that DCTH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -12.24, DCTH is not doing good in the industry: 81.38% of the companies in the same industry are doing better.
DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.24
ROIC/WACCN/A
WACC9.06%
DCTH Yearly LT Debt VS Equity VS FCFDCTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M -30M

2.3 Liquidity

DCTH has a Current Ratio of 1.34. This is a normal value and indicates that DCTH is financially healthy and should not expect problems in meeting its short term obligations.
DCTH's Current ratio of 1.34 is on the low side compared to the rest of the industry. DCTH is outperformed by 81.38% of its industry peers.
A Quick Ratio of 1.03 indicates that DCTH should not have too much problems paying its short term obligations.
DCTH has a Quick ratio of 1.03. This is in the lower half of the industry: DCTH underperforms 76.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.03
DCTH Yearly Current Assets VS Current LiabilitesDCTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.50% over the past year.
The Revenue has grown by 943.50% in the past year. This is a very strong growth!
Measured over the past years, DCTH shows a decrease in Revenue. The Revenue has been decreasing by -9.54% on average per year.
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
Revenue 1Y (TTM)943.5%
Revenue growth 3Y7.77%
Revenue growth 5Y-9.54%
Sales Q2Q%2480.65%

3.2 Future

Based on estimates for the next years, DCTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.66% on average per year.
DCTH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 144.90% yearly.
EPS Next Y72.73%
EPS Next 2Y39.21%
EPS Next 3Y29.95%
EPS Next 5Y19.66%
Revenue Next Year1628.05%
Revenue Next 2Y511.41%
Revenue Next 3Y292.52%
Revenue Next 5Y144.9%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DCTH Yearly Revenue VS EstimatesDCTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
DCTH Yearly EPS VS EstimatesDCTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -200M -400M -600M -800M -1B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DCTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DCTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DCTH Price Earnings VS Forward Price EarningsDCTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DCTH Per share dataDCTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as DCTH's earnings are expected to grow with 29.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.21%
EPS Next 3Y29.95%

More info and screens

0

5. Dividend

5.1 Amount

DCTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DELCATH SYSTEMS INC

NASDAQ:DCTH (2/21/2025, 8:12:57 PM)

After market: 15.5 +0.62 (+4.17%)

14.88

-0.66 (-4.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)03-06 2025-03-06/amc
Inst Owners31.1%
Inst Owner Change32.54%
Ins Owners2.69%
Ins Owner Change0.52%
Market Cap475.71M
Analysts85
Price Target22.23 (49.4%)
Short Float %3.29%
Short Ratio2.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)49.65%
Min EPS beat(2)-30.12%
Max EPS beat(2)129.41%
EPS beat(4)3
Avg EPS beat(4)28.34%
Min EPS beat(4)-30.12%
Max EPS beat(4)129.41%
EPS beat(8)3
Avg EPS beat(8)-8.06%
EPS beat(12)5
Avg EPS beat(12)-4.74%
EPS beat(16)8
Avg EPS beat(16)0.24%
Revenue beat(2)2
Avg Revenue beat(2)25.33%
Min Revenue beat(2)4.98%
Max Revenue beat(2)45.68%
Revenue beat(4)3
Avg Revenue beat(4)22.3%
Min Revenue beat(4)-2.21%
Max Revenue beat(4)45.68%
Revenue beat(8)3
Avg Revenue beat(8)-2.81%
Revenue beat(12)7
Avg Revenue beat(12)33.15%
Revenue beat(16)9
Avg Revenue beat(16)23.94%
PT rev (1m)2.17%
PT rev (3m)2.17%
EPS NQ rev (1m)54.29%
EPS NQ rev (3m)78.95%
EPS NY rev (1m)5.1%
EPS NY rev (3m)37.56%
Revenue NQ rev (1m)10.97%
Revenue NQ rev (3m)14.29%
Revenue NY rev (1m)3.94%
Revenue NY rev (3m)6.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.01
P/FCF N/A
P/OCF N/A
P/B 55.5
P/tB 55.5
EV/EBITDA N/A
EPS(TTM)-1.35
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.81
OCFYN/A
SpS0.71
BVpS0.27
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -107.71%
ROE -398.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.31%
FCFM N/A
ROA(3y)-135.11%
ROA(5y)-107.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.2%
GM growth 5Y-0.32%
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 259.7%
Cap/Sales 1.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.03
Altman-Z -12.24
F-Score4
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)100.06%
Cap/Depr(5y)153.71%
Cap/Sales(3y)4.82%
Cap/Sales(5y)12.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
EPS Next Y72.73%
EPS Next 2Y39.21%
EPS Next 3Y29.95%
EPS Next 5Y19.66%
Revenue 1Y (TTM)943.5%
Revenue growth 3Y7.77%
Revenue growth 5Y-9.54%
Sales Q2Q%2480.65%
Revenue Next Year1628.05%
Revenue Next 2Y511.41%
Revenue Next 3Y292.52%
Revenue Next 5Y144.9%
EBIT growth 1Y26.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.35%
EBIT Next 3Y44.45%
EBIT Next 5YN/A
FCF growth 1Y-8.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.73%
OCF growth 3YN/A
OCF growth 5YN/A